Laurent Humeau, Chief Scientific Officer at INOVIO PHARMACEUTICALS, INC. (INO), bought 4,500 shares at $2.22 ($10K) on 2019-08-30, disclosed to the SEC on 2019-09-04.
Open-market purchase of $10k INO by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| INO | SELL | 2020-11-12 | $380K | — | Filing → |
| INO | SELL | 2020-08-12 | $742K | — | Filing → |
| INO | SELL | 2020-06-24 | $572K | — | Filing → |